Portfolio | Indago Research

Charting a New Course for Weight Management

In this study, we will be working together to see if an investigational medicine is safe to use, and whether it can help people with overweight or obesity to lose weight and manage weight-related conditions. The investigational medicine is a monthly injection that is given subcutaneously (under the skin). Increasing physical activity and reducing the number of calories eaten does not necessarily lead to a reduction in weight for all individuals. As obesity continues to increase, this is a concern, as some diseases are known to occur more often in people with overweight or obesity.

18 - 55 years old

Clinical trial evaluating the effects of a natural prebiotic (Arrabina®P)

Participate in a Research Study on Satiety: You may qualify for a clinical trial evaluating the effects of a natural prebiotic (Arrabina®P) on appetite, mood, sleep, and more!

50-64 years of age Healthy

Potentially Help Prevent Seasonal Flu and COVID-19 With a Single Injection

The Duo P201 Trial Part 2 will evaluate the safety and immune response of 2 batches of an investigational combination vaccine aimed at preventing both seasonal flu and COVID-19 infections in adults 50 to 64 years of age.

55 to 90 years old

Mild to Moderate Alzheimer’s Disease Dementia Clinical Trial

A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of study drug as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia.

Can I join this study?

Yes, you may be able to join the research study if you:

Has mild to moderate AD dementia (ie, Stage 4 or Stage 5 AD) based on the Alzheimer’s Association Revised Criteria for Diagnosis and Staging of Alzheimer’s Disease.

Is an individual of any sex/gender, from 55 to 90 years of age inclusive, at the time of providing the informed consent as applicable.

The participant (or legally acceptable representative) has provided documented informed consent for the study.

Study Duration:

Study will require approximately 30 months from the time the first participant (or their legally acceptable representative) provides documented informed consent until the last participant’s last study-related contact.

More information:

Indago Research & Health Center, Inc.

Call: 305-825-6588

18 to 75 years old Diabetes

A clinical research study for people living with type 2 diabetes and excess weight GN02 Study

The GN02 study is a new clinical research study from Eli Lilly and Company. GN02 is a weight management study. It will test if an investigational medicine can safely reduce body weight in people with type 2 diabetes and obesity or overweight when compared to placebo.

Investigational medicine means it is still being tested in clinical research studies. A placebo looks the same as an investigational medicine but does not have any real medicine in it.

Can I join this study?

Yes, you may be able to join the study if you:

are aged 18 to 75 years
cannot become pregnant
have type 2 diabetes that you treated with diet and exercise alone or with a stable dose of metformin.
have not taken insulin in the past year, and
have a BMI of 27kg/m ² or more

BMI stands for body mass index. It is a number that compares a person’s weight to their height. It can be used to tell if a person may be at risk of some health conditions.

For more information: 786-772-0510

18-64 years old 65+ years

One and done

Learn more about Pfizer and BioNTech’s clinical trial for an investigational COVID-19 and flu vaccine using mRNA technology

18 years or older

Are you at a higher risk of experiencing severe illness from COVID-19?

Researchers are testing an investigational medicine for COVID-19. They want to know how well it may work and if it is safe in adults with COVID-19 who are at a higher risk for severe illness from COVID-19.

18- 65 years old

One and done: Help make dual protection against COVID-19 and flu possible with a combination vaccine

Help make dual protection against COVID-19 and flu possible with a combination vaccine

18 years or older

Learning more about a potential new cholesterol drug is at the heart of our study

Join a clinical study testing the effects of an investigational oral drug on blood pressure.

55-80 years old

A clinical research study for people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease

TRAILRUNNER-ALZ 3 is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine may help treat people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease.

Older Posts

Charting a New Course for Weight Management

Clinical trial evaluating the effects of a natural prebiotic (Arrabina®P)

Potentially Help Prevent Seasonal Flu and COVID-19 With a Single Injection

Mild to Moderate Alzheimer’s Disease Dementia Clinical Trial

Can I join this study?

Yes, you may be able to join the research study if you:

Study Duration:

More information:

A clinical research study for people living with type 2 diabetes and excess weight GN02 Study

Can I join this study?

One and done

Are you at a higher risk of experiencing severe illness from COVID-19?

One and done: Help make dual protection against COVID-19 and flu possible with a combination vaccine

Learning more about a potential new cholesterol drug is at the heart of our study

A clinical research study for people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease

Working Hours

Quick Links

Connect